Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10694794 | 0.89 | KDM4E (0.59) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL10694789 | 0.89 | KDM4E (0.59) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL15491125 | 0.85 | DNM1 (0.55) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL8748455 | 0.85 | APEX1 (0.49) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL10694876 | 0.85 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL13919933 | 0.84 | ALDH1A1 (0.59) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL9680658 | 0.83 | POLB (0.59) | ALDH1A1KDM4ETDP1DNM1POLB | |
| SCHEMBL12477636 | 0.83 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL141604 | 0.83 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAPTKMT2ATDP1 | |
| SCHEMBL12372703 | 0.83 | KDM4E (0.56) | ALDH1A1KDM4EMAPTKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989572-B2 | Polyvinyl ultraviolet light absorbers for personal care | EASTMAN CHEMICAL COMPANY (US) | 2011-08-02 | — | — | US | disclosed |
| WO-2009091506-A2 | POLYVINYL ULTRAVIOLET LIGHT ABSORBERS FOR PERSONAL CARE | EASTMAN CHEMICAL COMPANY (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090185988-A1 | POLYVINYL ULTRAVIOLET LIGHT ABSORBERS FOR PERSONAL CARE | EASTMAN CHEMICAL COMPANY (US) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090185988-A1 | POLYVINYL ULTRAVIOLET LIGHT ABSORBERS FOR PERSONAL CARE | MMS19, XPA, CUTA | ALDH1A1 1754/4885KDM4E 3348/4885MAPT 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.